Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Immunogenicity and Safety of Swine-origin A/H1N1 Influenza Vaccine in Adults and Elderly
NCT00954798Phase 2Completed
- Sponsor
- Sanofi
- Start
- Aug 2009
- Primary completion
- Dec 2010
- Modality
- Live Attenuated Vaccines, Whole Inactivated Vaccines
- Countries
- 1
01
Overview
A Phase 2 trial of Influenza A (H1N1) vaccine in influenza A H1N1 infection (H1N1), sponsored by Sanofi. Started Aug 2009; status: completed.
02
Drugs
Influenza A (H1N1) vaccine
03
Conditions
influenza A H1N1 infection (H1N1)
Beyond the preview
Go deeper on NCT00954798.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00954798.